Literature DB >> 1254560

Lipid composition and lipid metabolism of Spiroplasma citri.

B A Freeman, R Sissenstein, T T McManus, J E Woodward, I M Lee, J B Mudd.   

Abstract

In a horse serum-based medium containing a full complement of fatty acids, cells of Spiroplasma citri were seen to preferentially incorporate palmitic acid. In the same medium, which had a steryl ester-to-sterol ratio of 3.64, a steryl ester-to-sterol ratio of 0.23 was seen in the cells, cholesterol being preferentially incorporated over cholesteryl ester. Like most other mycoplasmas, S. citri was shown to be unable to synthesize fatty acids or esterify cholesterol. The neutral lipids of S. citri grown in a medium containing horse serum consisted of free cholesterol, cholesteryl ester, free fatty acids, triglycerides and diglycerides. All polar lipids were phospholipids, with no glycolipids detected. These phospholipids, which are characteristic of many mycoplasmas, are phosphatidyl glycerol, diphosphatidyl glycerol, and their lyso derivatives. Sphingomyelin was also incorporated when cells were grown on horse serum. A sterol requirement for the growth of S. citri was confirmed using a serum-free medium supplemented with bovine serum albumin, palmitic acid, and various concentrations of sterols dissolved in Tween 80. The addition of palmitic acid stimulated growth but was not essential for growth. S citri was shown to grow best on cholesterol and beta-sitosterol and was able to grow on stigmasterol and ergosterol to a lesser degree. No growth was obtained using mevalonate, deoxycholate, or taurodeoxycholate as an alternative to sterol. S. citri was also able to grow when palmitic acid was replaced with oleic acid, linoleic acid, or linolenic acid. Alterations in the lipid composition of the growth medium and hence in the lipid composition of S. citri induced changes in the characteristic helical morphology of the cells, concurrent with loss of cell viability. Culture, age, and pH were also factors in determining cell morphology and viability.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254560      PMCID: PMC236170          DOI: 10.1128/jb.125.3.946-954.1976

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

2.  CHOLESTEROL AND CHOLESTEROL ESTERS IN MYCOPLASMA.

Authors:  M ARGAMAN; S RAZIN
Journal:  J Gen Microbiol       Date:  1965-01

3.  Detection of sugars on paper chromatograms.

Authors:  W E TREVELYAN; D P PROCTER; J S HARRISON
Journal:  Nature       Date:  1950-09-09       Impact factor: 49.962

4.  Binding of proteins to mycoplasma membranes.

Authors:  S Rottem; M Hasin; S Razin
Journal:  Biochim Biophys Acta       Date:  1973-04-16

5.  Incorporation of plant sterols into membranes and its relation to sterol absorption.

Authors:  P A. Edwards; C Green
Journal:  FEBS Lett       Date:  1972-01-15       Impact factor: 4.124

6.  Effects of free sterols, steryl ester, and steryl glycoside on membrane permeability.

Authors:  C Grunwald
Journal:  Plant Physiol       Date:  1971-11       Impact factor: 8.340

7.  Cholesterol in mycoplasma membranes. II. Components of Acholeplasma laidlawii cell membranes responsible for cholesterol binding.

Authors:  S Razin; M Wormser; N L Gershfeld
Journal:  Biochim Biophys Acta       Date:  1974-06-29

8.  Morphology, ultrastructure, and bacteriophage infection of the helical mycoplasma-like organism (Spiroplasma citri gen. nov., sp. nov.) cultured from "stubborn" disease of citrus.

Authors:  R M Cole; J G Tully; T J Popkin; J M Bové
Journal:  J Bacteriol       Date:  1973-07       Impact factor: 3.490

9.  Calorimetric evidence for the liquid-crystalline state of lipids in a biomembrane.

Authors:  J M Steim; M E Tourtellotte; J C Reinert; R N McElhaney; R L Rader
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

10.  Metabolic turnover of the polar lipids of Mycoplasma laidlawii strain B.

Authors:  R N McElhaney; M E Tourtellotte
Journal:  J Bacteriol       Date:  1970-01       Impact factor: 3.490

View more
  18 in total

1.  Role of the S layer in morphogenesis and cell division of the archaebacterium Methanocorpusculum sinense.

Authors:  D Pum; P Messner; U B Sleytr
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

2.  Chemically defined medium for cultivation of several epiphytic and phytopathogenic spiroplasmas.

Authors:  I M Lee; R E Davis
Journal:  Appl Environ Microbiol       Date:  1983-12       Impact factor: 4.792

3.  Characterization of lysocardiolipin from Acinetobacter sp. HO1-N.

Authors:  R E Torregrossa; R A Makula; W R Finnerty
Journal:  J Bacteriol       Date:  1977-08       Impact factor: 3.490

4.  Topology and acylation of spiralin.

Authors:  H Wróblewski; S Nyström; A Blanchard; A Wieslander
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

5.  Effect of external environmental factors on the morphology of Spiroplasma citri.

Authors:  K R Patel; K J Mayberry-Carson; P F Smith
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490

Review 6.  The mycoplasmas.

Authors:  S Razin
Journal:  Microbiol Rev       Date:  1978-06

7.  Growth and division of spiroplasmas: morphology of Spiroplasma citri during growth in liquid medium.

Authors:  M Garnier; M Clerc; J M Bove
Journal:  J Bacteriol       Date:  1981-08       Impact factor: 3.490

8.  Spiroplasma membrane lipids.

Authors:  P J Davis; A Katznel; S Razin; S Rottem
Journal:  J Bacteriol       Date:  1985-01       Impact factor: 3.490

9.  Composition and enzyme activities of Spiroplasma citri membranes.

Authors:  J B Mudd; M Ittig; B Roy; J Latrille; J M Bové
Journal:  J Bacteriol       Date:  1977-03       Impact factor: 3.490

10.  Lecithin changes in murine Mycoplasma pulmonis respiratory infection.

Authors:  J D Pollack; H S Weiss; N L Somerson
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.